Company / Operating Cash Flow
Gossamer Bio, Inc. Operating Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$171.3M
FY2025
5-year range
-$188.9M / -$3.5M
FY2021-FY2025
Trend
-4838.5%
vs FY2024
Sector context
#160 of 216
Health Care
What the data says
Operating Cash Flow changed -4838% YoY in FY2025, a notable deviation from the 8-year average annual change of -716%.
Based on SEC 10-K filings.
-$171M in FY2025.
Declined from -$159M to -$171M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#160 of 216 in Health CareTop 74% of 216This company -$171.3M Sector average $658.7M
▼
-126.0% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 4838.5% year-over-year.
- Ranks #160 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$171.3M | -4838.5% |
| FY2024 | -$3.5M | +97.8% |
| FY2023 | -$159.2M | +14.9% |
| FY2022 | -$187.0M | +1.0% |
| FY2021 | -$188.9M | -7.1% |
| FY2020 | -$176.4M | -21.8% |
| FY2019 | -$144.8M | -183.7% |
| FY2018 | -$51.0M | -788.5% |
| FY2017 | -$5.7M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026